Cara Therapeutics Inc is a development-stage biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus... Show more
CARA moved above its 50-day moving average on April 14, 2025 date and that indicates a change from a downward trend to an upward trend. In of 32 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on April 14, 2025. You may want to consider a long position or call options on CARA as a result. In of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for CARA just turned positive on April 14, 2025. Looking at past instances where CARA's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .
Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where CARA advanced for three days, in of 265 cases, the price rose further within the following month. The odds of a continued upward trend are .
a developer of pharmaceutical products
Industry Biotechnology